Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: RIEMSER Arzneimittel GmbH (1) Acquired (1)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
methantheline bromide (banthine) (1 trial)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Urinary Bladder, Neurogenic (Phase 1)
Trials (3 total)
Trial APIs (3 total)